iLivTouch vs FibroScan
See why clinicians are choosing guided liver elastography over traditional blind point-and-shoot devices. The difference is clear.
FibroScan comparisons on this page refer to commonly deployed standard models (for example 502 Touch, 530 Compact). The FibroScan 630 Expert includes ultrasound localization and additional outputs.
iLivTouch
Guided Elastography
- 2D Ultrasound Imaging
- ~96.5% Success (NAFLD cohort)
- ~$80,000–$90,000 AUD (indicative)
- Single Universal Probe
FibroScan
Standard TE (typical install)
- No Imaging Guidance
- ~85% Success Rate
- ~$100,000+ AUD (new)
- Multiple Probes Required
Guided vs Blind: The Core Difference
Understanding why imaging guidance matters for accurate liver assessment.
iLivTouch (Guided TE)
Recommended- Real-time B-mode ultrasound imaging shows exact probe position
- Operator can see liver parenchyma and avoid vessels
- Visual confirmation of measurement location before acquisition
- Immediate feedback on positioning quality
- Reduced operator dependency — you see what you're measuring
FibroScan (Blind VCTE)
Traditional- Most installed systems (502/530) have no B-mode for targeting
- Cannot visualise liver parenchyma during acquisition
- Relies on external landmarks and operator experience
- 630 Expert adds localisation — not full guided imaging
- XL probe mitigates some high-BMI limits but doesn't add visual guidance
Feature by Feature
Detailed Comparison
Accuracy & Reliability
Real-time visualization
No B-mode; 630 Expert adds ultrasound localization
Large published NAFLD FibroTouch cohort
Depends on probe, operator, patient
See published studies
XL probe improves vs M in obesity
Quality threshold
Quality threshold
See structures in real-time
No visual guidance on standard units
Fibrosis, steatosis, imaging
630 Expert also offers SSM + ultrasound
Cost & Investment
Indicative — request quote
New standard models
All patient types
M, XL probes sold separately
Universal design
Per additional probe
2-year included
Contract required
On-site training
Certification program
Workflow & Efficiency
Complete examination
Including repositioning
Visual guidance helps
Blind technique
Auto-generated
Auto-generated
Standard format
Standard format
Visual confirmation
Must be precise
Patient Success
Guided acquisition; see studies
XL probe often used
Visual guidance
Limited positioning
Can identify and avoid
Cannot visualize
Guided positioning
May be challenging
Gentle approach
With care
FibroScan in high-BMI patients
A primary driver for clinics evaluating alternatives is the performance of traditional blind elastography in obese patients. Published literature indicates that the classic FibroScan M-probe can experience failure rates of 20–25% in cohorts with a BMI > 30.
While the FibroScan XL probe was developed to mitigate this by adjusting the focal depth, it requires purchasing and maintaining a second probe, and the operator is still acquiring measurements without visual confirmation of the liver parenchyma. Guided elastography addresses the root cause by allowing the clinician to see exactly where the shear wave is being generated.
Who should consider the guided alternative?
- 1New clinic setupsAvoid the ~$100k+ capital burden of new legacy systems. Guided elastography is typically a significantly lower capital commitment than comparable new FibroScan, with a faster path to ROI for many practices.
- 2High-BMI cohortsIf your practice manages high volumes of MAFLD, obesity, or type 2 diabetes, 2D guidance is essential for reliable acquisition.
- 3Previous TE failuresClinics frustrated by high IQR ratios or the constant need to switch probes find immediate workflow relief with a universal guided probe.
- 4Primary care screeningWhen evaluating a patient with an indeterminate FIB-4 score, you need a reliable, cost-effective second-line test.
The Verdict
Guided elastography systems supplied through Elastography Australia offer the same core outputs as standard FibroScan workflows, plus real-time imaging guidance that can improve confidence—especially in challenging patients—often at significantly lower capital than comparable new FibroScan.
Common questions
Which is better — FibroScan or elastography?
Both iLivTouch and FibroScan use transient elastography (TE) to measure liver stiffness in kPa. The relevant comparison is between blind TE (FibroScan standard models) and guided TE (iLivTouch). Guided systems use real-time B-mode ultrasound imaging to position the probe before acquisition, which improves success rates in obese patients and reduces operator dependency. Both technologies are clinically validated and guideline-supported.
Is iLivTouch better than FibroScan?
Both devices perform transient elastography (TE) — the same gold-standard technology for liver stiffness measurement. The critical difference is guidance: iLivTouch adds real-time B-mode ultrasound imaging so the operator can see exactly where the measurement is being taken. Standard FibroScan models are blind — the operator cannot visualise the liver during acquisition. For patients with high BMI or narrow intercostal spaces, guided systems achieve significantly higher acquisition success rates.
iLivTouch vs FibroScan — what's the technology difference?
Both use transient elastography: a mechanical vibration creates a shear wave in liver tissue, and the velocity of that wave is converted to a stiffness value in kPa using the elastic modulus equation (E = 3ρV²). The difference is guidance. iLivTouch integrates real-time B-mode ultrasound imaging so the operator can confirm they are measuring appropriate liver parenchyma, avoid vessels, and validate placement before accepting measurements. Standard FibroScan models acquire measurements without this visual confirmation — a limitation that becomes clinically significant in high-BMI patients.
Further Reading
Mar 2026
FibroScan Alternatives Australia: Guided Elastography Buyer's Guide
What Australian buyers evaluate when comparing transient elastography systems: guidance, workflow, obese-patient performance, probes, and total cost of ownership.
Mar 2026
Liver Scan in Obese Patients: Australian Clinic Guide
Operational guide to non-invasive liver assessment in higher-BMI cohorts, including workflow and acquisition considerations.
Apr 2026
FibroScan Limitations: Australian Clinic Guide
FibroScan has documented limitations in obese patients, workflow efficiency, and operator guidance. What the evidence shows and why guided TE addresses the root causes.